CHM 12.5% 1.8¢ chimeric therapeutics limited

Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation, page-19

  1. 760 Posts.
    lightbulb Created with Sketch. 524
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.